ERBB2 and breast carcinoma: Arab A et al75 developed effective vaccine delivery/auxiliary systems by connecting the epitope E75, which was derived from the highly expressed antigen HER2 in breast cancer patients, with the liposome containing distearoyl phosphatidylcholine (DSPC) and distearoyl phosphatidylglycerole (DSPG).